May 04, 2016 02:29 PM IST
Ashwani Gujral of ashwanigujral.com recommends buying Indraprastha Medical and advises selling Indo Count Industries and Cairn India.
Mar 22, 2016 08:14 AM IST
CA Rudramurthy BV of Vachana Investments is of the view that one may buy Aurobindo Pharma with a target of Rs 780.
Nov 30, 2015 08:47 AM IST
Manish Sharma of Derivative Trading Research recommends selling Ceat with a target of Rs 970 and Amara Raja with a target of Rs 840.
Jul 27, 2015 08:16 AM IST
Sharmila Joshi, Market Expert advises buying Biocon with a target of Rs 478.
Jul 29, 2013 12:52 PM IST
SP Tulsian of sptulsian.com feels that Indraprastha Medical Corporation can move to about Rs 40 maybe in six months. "It has 700 beds hospital in Delhi, which is one of the largest hospitals in the country and they have the capacity to expand to 1,000 beds as well," he adds.
Jul 29, 2013 09:37 AM IST
SP Tulsian of sptulsian.com asks traders to keep a view of about six months and look for a target of Rs 500 on Torrent Pharmaceuticals. He expects Indraprastha Medical Corporation, which is now ruling at around Rs 33, to move to Rs 40 maybe in six months or so.
May 25, 2012 09:13 AM IST
Indraprastha Medical can move to Rs 50 in next twelve months, says SP Tulsian, sptulsian.com.
Oct 07, 2011 09:47 AM IST
Hold Indraprastha Medical Corporation for long term, says Aashish Tater, Head of Research, Fort Share Broking.